Walvax Biotechnology Co.,Ltd.’s Net Profit Rose 42.2% in First Three Quarters of 2022

Walvax Biotechnology Co.,Ltd. (云南沃森生物技术股份有限公司) (300142.SZ) reported a net profit of 688.7 million yuan in the first three quarters of 2022, up 42.2% year-on-year.

Meanwhile, the company posted 3.7 billion yuan in revenue, up 74.1% year-on-year.

At the end of the reporting period, it had 14.8 billion yuan in total assets and 4.1 billion yuan in total liabilities, with a liability-to-asset ratio of 27.5%.